Dell Technologies HPC Community Event
About the Event
HPC and accelerator-driven computing have become pivotal to drive research in Pharma. Where 5 years ago less than 1% of the researchers actively used HPC resources, AstraZeneca is driving a clear strategy to gain the majority of insights by 2025 through data and AI. This ambition is leading to a constant change in how our researchers work and are presenting an unstoppable appetite for computing.
We will discuss the journey of the last 5 years renewing the approach we are taking towards high-performance computing, explore use cases that are leveraging compute in significantly different ways, driving our research in innovative ways, and share an outlook and vision into our future direction.
About the Speaker
Justin Lecher, Platform Lead Scientific Computing, Astrazeneca
Justin Lecher is driving the continuous effort in AstraZeneca to build out versatile HPC, HTC, and accelerator-driven environments to supply computing to a large heterogeneous computing space. Since joining AstraZeneca he has been leading the design and build of today’s Scientific Computing Platform which supports scientists across the globe every day.
He has been gaining his interest and enthusiasm for computing in life science as a researcher levering HPC resources to drive insights into molecular structure, dynamics, and function of membrane proteins involved in human cell signaling.
Check out future events scheduled for the Dell Technologies HPC Community.